Cargando…
Clinical Benefits Over Time Associated with Use of V-Go Wearable Insulin Delivery Device in Adult Patients with Diabetes: A Retrospective Analysis
INTRODUCTION: Advances in insulin delivery have improved outcomes in patients with diabetes. This study evaluated the impact of V-Go(®) Wearable Insulin Delivery device on glycated hemoglobin (A1C) and insulin total daily dose (TDD) in patients with diabetes not achieving glycemic targets. METHODS:...
Autores principales: | Sutton, David, Higdon, Charissa D., Nikkel, Carla, Hilsinger, Karrie A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960483/ https://www.ncbi.nlm.nih.gov/pubmed/29748915 http://dx.doi.org/10.1007/s12325-018-0703-3 |
Ejemplares similares
-
Regular Insulin Administered With the V-Go Disposable Insulin Delivery Device in a Clinical Diabetes Setting: A Retrospective Analysis of Efficacy and Cost
por: Sutton, David, et al.
Publicado: (2016) -
Clinical Evaluation of Basal-Bolus Therapy Delivered by the V-Go(®) Wearable Insulin Delivery Device in Patients with Type 2 Diabetes: A Retrospective Analysis
por: Zeidan, Trisha, et al.
Publicado: (2020) -
The Clinical and Economic Impact of the V-Go(®) Disposable Insulin Delivery Device for Insulin Delivery in Patients with Poorly Controlled Diabetes at High Risk
por: Lajara, Rosemarie, et al.
Publicado: (2016) -
Multicenter Real-World Assessment of the Effectiveness of V-Go Wearable Insulin Delivery Device in Adult Patients with Type 2 Diabetes (ENABLE Study): A Retrospective Analysis
por: Hundal, Ripu, et al.
Publicado: (2020) -
Efficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device in type 2 diabetes
por: Mora, Pablo F, et al.
Publicado: (2020)